Depressed patients (n = 10), schizophrenics (n = 6), and normal control subjects was (n = 9) were administered fenfluramine hydrochloride (FF) (60 mg/os) or placebo in the context of a randomized, double-blind crossover trial. No effect of FF on mood or activation was detected over a 6-hr period. A previous report claiming acute antidepressant effects of FF in depressed subjects was not confirmed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0006-3223(92)90228-r | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!